What is Dravet Syndrome?

Dravet syndrome, also known as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare form of intractable epilepsy that begins in infancy and proceeds with accumulating morbidity that significantly impacts individuals throughout their lifetime. It has an estimated incidence rate of 1:15,700. [1]

Community. Research. Progress.

Raising Hope & Changing Lives through Research

The mission of Dravet Syndrome Foundation (DSF) is to aggressively raise funds for Dravet syndrome and related epilepsies; to support and fund research; increase awareness; and to provide support to affected individuals and families.

We know that the fight against Dravet syndrome will never be successful without teamwork. None of us can do this alone and to achieve great things we must work together.

Thanks to the collective efforts of our community, DSF has achieved numerous milestones to celebrate. Become a part of #TeamDSF by donating, launching a personal fundraising campaign, or exploring other ways to give.

DSF Recent News & Information

Keep up to date on current information that is important to you in our weekly Decoding Dravet Blog posts and through our email updates.  

Meet our 2025 TCS New York City Marathon Runners!

On Sunday, November 2nd, a dedicated team of six runners will take on the iconic streets of New York City in the world-renowned NYC Marathon—all ...
Read More →

DSF-Funded Study Aims to Change the “Trial-and-Error” Approach to Treatment for Dravet Syndrome

Despite having several FDA-approved therapies and clear treatment guidelines, the approach to treat seizures for Dravet syndrome can often be a repeating cycle of ‘trial-and-error’ ...
Read More →

Longitudinal Insights: Gathering Natural History Data for Dravet Syndrome

DSF recently announced funding for a Longitudinal Dravet Syndrome Natural History Study led by Dr. Kelly Knupp with The Dravet Lifespan Multidisciplinary Clinic at Children’s ...
Read More →
Scroll to Top